Skip to main content
INMB
NASDAQ Life Sciences

Inmune Bio Prices $4.5M Stock Sale at $1.50 With Matching Warrant Package

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.52
Mkt Cap
$42.463M
52W Low
$1.09
52W High
$2.6
52W Position info
39% above low
Off High info
42% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

INMB sits 39% above its 52-week low of $1.09.

Summary

Inmune Bio priced a $4.5 million sale of 3,000,000 shares at $1.50, bundled with 3,000,000 warrants at a $1.65 strike, netting about $4.0 million for CORDStrom development and working capital.


Key Events · Financing and Capital Events · INMB

  • Priced $4.5M Stock and Warrant Deal

    3,000,000 shares sold at $1.50 for $4,500,000 gross, plus a concurrent private placement of 3,000,000 warrants at a $1.65 exercise price — 100% warrant coverage.

  • Net Proceeds About $4.0 Million

    A.G.P. takes a 7.0% cash fee of $315,000, leaving $4,185,000 before expenses and roughly $4.0 million net. Full warrant exercise would add about $4.95 million more.

  • Immediate $0.67 Per Share Dilution

    Pro forma as adjusted net tangible book value rises to $0.83 per share from $0.78, so buyers at $1.50 absorb $0.67 of dilution; shares outstanding go to 30,959,079 from 27,959,079.

  • Cash Covers Only a Short Runway

    Pro forma cash of $23,751,000 versus $18,411,000 actual at June 30, 2026, against a going-concern warning previously disclosed in the Q2 2026 10-Q.


Analysis · INMB · Life Sciences

Inmune Bio is raising $4.5 million gross by selling 3,000,000 shares at $1.50, and the single healthcare-focused investor also receives 3,000,000 warrants struck at $1.65 that become exercisable in April 2027. Net proceeds of roughly $4.0 million land against $18.4 million of cash at June 30, 2026 and a going-concern warning previously disclosed in the Q2 10-Q — this buys months, not years, ahead of the February 2027 UK MAA filing. The cost is real: new buyers take $0.67 per share of immediate net tangible book value dilution, and full warrant exercise would add another $4.95 million and 3,000,000 shares. The 7.0% placement fee and 60-day insider lock-up are standard for a deal this size.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INMB was trading at $1.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $42.5M. The 52-week trading range was $1.09 to $2.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INMB - Latest Insights

INMB
Nov 05, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.18
Real-time Price: $1.05 info
Change: -$0.125 (-11%) info
Market Cap: $32.507M info
INMB
Oct 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.41
Real-time Price: $1.05 info
Change: -$0.360 (-26%) info
Market Cap: $32.507M info
INMB
Oct 21, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.69
Real-time Price: $1.05 info
Change: -$0.639 (-38%) info
Market Cap: $32.507M info
INMB
Oct 21, 2026, 7:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $1.05 info
Change: -$0.580 (-36%) info
Market Cap: $32.507M info
INMB
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.03
Real-time Price: $1.05 info
Change: -$0.980 (-48%) info
Market Cap: $32.507M info